Kenneth Chavin, MD, PHD

NPI: 1801901731
Total Payments
$14,584
2024 Payments
$235.77
Companies
19
Transactions
28
Medicare Patients
244
Medicare Billing
$76,761

Payment Breakdown by Category

Research$10,000 (68.6%)
Consulting$3,375 (23.1%)
Food & Beverage$1,062 (7.3%)
Education$147.00 (1.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $10,000 1 68.6%
Consulting Fee $3,375 2 23.1%
Food and Beverage $1,062 22 7.3%
Education $147.00 3 1.0%

Payments by Type

Research
$10,000
1 transactions
General
$4,584
27 transactions

Top Paying Companies

Company Total Records Latest Year
Bridge to Life Ltd $10,000 1 $0 (2019)
Jazz Pharmaceuticals Inc. $2,870 1 $0 (2020)
Ethicon US, LLC $578.28 5 $0 (2021)
SANOFI-AVENTIS U.S. LLC $213.14 2 $0 (2024)
Veloxis Pharmaceuticals, Inc. $204.52 2 $0 (2018)
La Jolla Pharmaceutical Company $147.00 3 $0 (2020)
Davol Inc. $141.38 1 $0 (2017)
Biocompatibles, Inc. $112.10 1 $0 (2017)
CSL Behring $80.19 1 $0 (2017)
Organ Recovery Systems, Inc. $51.71 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $235.77 3 SANOFI-AVENTIS U.S. LLC ($213.14)
2022 $56.71 3 GENZYME CORPORATION ($39.39)
2021 $536.34 3 Ethicon US, LLC ($536.34)
2020 $3,033 5 Jazz Pharmaceuticals Inc. ($2,870)
2019 $10,053 4 Bridge to Life Ltd ($10,000)
2018 $321.70 6 Veloxis Pharmaceuticals, Inc. ($204.52)
2017 $348.05 4 Davol Inc. ($141.38)

All Payment Transactions

28 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
07/23/2024 Merck Sharp & Dohme LLC PREVYMIS (Drug) Food and Beverage In-kind items and services $22.63 General
Category: INFECTIOUS DISEASE
06/02/2024 SANOFI-AVENTIS U.S. LLC THYMOGLOBULIN (Biological) Food and Beverage In-kind items and services $94.68 General
Category: Oncology
01/24/2024 SANOFI-AVENTIS U.S. LLC THYMOGLOBULIN (Biological) Food and Beverage In-kind items and services $118.46 General
Category: Oncology
11/03/2022 GENZYME CORPORATION AUBAGIO (Drug) Food and Beverage In-kind items and services $20.39 General
Category: Neurology
04/14/2022 GENZYME CORPORATION AUBAGIO (Drug) Food and Beverage In-kind items and services $19.00 General
Category: Neurology
04/14/2022 Takeda Pharmaceuticals U.S.A., Inc. LIVTENCITY (Drug) Food and Beverage In-kind items and services $17.32 General
Category: IMMUNOLOGY
10/20/2021 Ethicon US, LLC Echelon; Endopath (Device), Echelon Flex Consulting Fee Cash or cash equivalent $505.00 General
Category: Endo-Mechanical
09/21/2021 Ethicon US, LLC Harmonic (Device) Food and Beverage In-kind items and services $11.70 General
Category: Energy
01/20/2021 Ethicon US, LLC Echelon; Endopath (Device), ETHICON Food and Beverage In-kind items and services $19.64 General
Category: Endo-Mechanical
06/11/2020 Ethicon US, LLC Surgicel Powder (Device) Food and Beverage In-kind items and services $15.69 General
Category: Biosurgical
03/30/2020 Jazz Pharmaceuticals Inc. DEFITELIO (Drug) Consulting Fee Cash or cash equivalent $2,870.00 General
Category: HEMATOLOGY/ONCOLOGY
01/31/2020 La Jolla Pharmaceutical Company GIAPREZA (Drug) Education In-kind items and services $51.00 General
Category: EMERGENT HYPOTENSION
01/31/2020 La Jolla Pharmaceutical Company GIAPREZA (Drug) Education In-kind items and services $48.00 General
Category: EMERGENT HYPOTENSION
01/23/2020 La Jolla Pharmaceutical Company GIAPREZA (Drug) Education In-kind items and services $48.00 General
Category: EMERGENT HYPOTENSION
07/31/2019 Mallinckrodt Enterprises LLC ACTHAR (Biological) Food and Beverage In-kind items and services $11.13 General
Category: AUTOIMMUNE AND RARE DISEASE
06/26/2019 Incyte Corporation Food and Beverage Cash or cash equivalent $24.61 General
05/08/2019 E.R. Squibb & Sons, L.L.C. NULOJIX (Biological) Food and Beverage Cash or cash equivalent $17.08 General
Category: Immunology
01/19/2019 Bridge to Life Ltd Stock, stock option, or any other ownership interest $10,000.00 Research
Study: Papain
12/07/2018 Baxter Healthcare FLOSEAL (Biological) Food and Beverage In-kind items and services $14.89 General
Category: Surgical Care
11/28/2018 Veloxis Pharmaceuticals, Inc. Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR Food and Beverage In-kind items and services $183.72 General
Category: Immunosuppressant
11/28/2018 Veloxis Pharmaceuticals, Inc. Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR Food and Beverage In-kind items and services $20.80 General
Category: Immunosuppressant
05/01/2018 Novartis Pharmaceuticals Corporation ZORTRESS (Drug) Food and Beverage In-kind items and services $24.33 General
Category: IMMUNOLOGY
01/12/2018 Organ Recovery Systems, Inc. Food and Beverage Cash or cash equivalent $51.71 General
01/10/2018 Ethicon US, LLC PROLENE Polypropylene Suture (Device) Food and Beverage In-kind items and services $26.25 General
Category: Sutures
12/11/2017 Biocompatibles, Inc. THERASPHERE - BIO (Device) Food and Beverage In-kind items and services $112.10 General
Category: INTERVENTIONAL ONCOLOGY

Research Studies & Clinical Trials

Study Name Company Amount Records
Papain Bridge to Life Ltd $10,000 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 61 93 $199,370 $42,432
2021 3 65 151 $34,144 $13,930
2020 4 118 238 $53,004 $20,399
Total Patients
244
Total Services
482
Medicare Billing
$76,761
Procedure Codes
11

All Medicare Procedures & Services

11 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
50360 Transplantation of donor kidney Facility 2023 17 17 $138,210 $30,153 21.8%
50605 Insertion of stent in ureter Facility 2023 18 18 $51,120 $7,083 13.9%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 15 42 $5,880 $2,781 47.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 11 16 $4,160 $2,416 58.1%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 20 101 $21,614 $8,298 38.4%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 31 36 $8,568 $4,115 48.0%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 14 14 $3,962 $1,516 38.3%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 40 130 $27,820 $10,895 39.2%
99215 Established patient office or other outpatient, visit typically 40 minutes Facility 2020 39 64 $15,232 $5,683 37.3%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 24 24 $6,792 $2,619 38.6%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 15 20 $3,160 $1,201 38.0%

About Kenneth Chavin, MD, PHD

Kenneth Chavin, MD, PHD is a Transplant Surgery healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801901731.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kenneth Chavin, MD, PHD has received a total of $14,584 in payments from pharmaceutical and medical device companies, with $235.77 received in 2024. These payments were reported across 28 transactions from 19 companies. The most common payment nature is "" ($10,000).

As a Medicare-enrolled provider, Chavin has provided services to 244 Medicare beneficiaries, totaling 482 services with total Medicare billing of $76,761. Data is available for 3 years (2020–2023), covering 11 distinct procedure/service records.

Practice Information

  • Specialty Transplant Surgery
  • Other Specialties Surgery
  • Location Philadelphia, PA
  • Active Since 08/20/2006
  • Last Updated 09/28/2022
  • Taxonomy Code 204F00000X
  • Entity Type Individual
  • NPI Number 1801901731

Products in Payments

  • DEFITELIO (Drug) $2,870
  • Echelon; Endopath (Device) $524.64
  • THYMOGLOBULIN (Biological) $213.14
  • Envarsus XR (SP) (Drug) $204.52
  • GIAPREZA (Drug) $147.00
  • DAV-Phasix (Device) $141.38
  • THERASPHERE - BIO (Device) $112.10
  • Product in Development (Biological) $80.19
  • AUBAGIO (Drug) $39.39
  • PROLENE Polypropylene Suture (Device) $26.25
  • ZORTRESS (Drug) $24.33
  • PREVYMIS (Drug) $22.63
  • LIVTENCITY (Drug) $17.32
  • NULOJIX (Biological) $17.08
  • Surgicel Powder (Device) $15.69
  • FLOSEAL (Biological) $14.89
  • PICO (Device) $14.38
  • Harmonic (Device) $11.70
  • ACTHAR (Biological) $11.13

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Transplant Surgery Doctors in Philadelphia